FDA Enforcement In Brief
This article was originally published in The Tan Sheet
Executive Summary
MRSA claims attract hand sanitizer sweep
You may also be interested in...
Hand Sanitizers Limited To Sterile Claims But Cleaning Up Amid Flu Worries
Consumer fears stemming from a second wave of 2009-H1N1 flu virus cases are helping drive sales of hand sanitizers, but marketers must tread lightly when it comes to associating their products with protection against viruses
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.